- Home
- ATLO vs PBYI Comparison
ATLO vs PBYI Comparison
Compare ATLO & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLO
- PBYI
- Stock Information
- Founded
- ATLO 1903
- PBYI 2010
- Country
- ATLO United States
- PBYI United States
- Employees
- ATLO N/A
- PBYI N/A
- Industry
- ATLO Major Banks
- PBYI Biotechnology: Pharmaceutical Preparations
- Sector
- ATLO Finance
- PBYI Health Care
- Exchange
- ATLO Nasdaq
- PBYI Nasdaq
- Market Cap
- ATLO 166.6M
- PBYI 154.1M
- IPO Year
- ATLO N/A
- PBYI N/A
- Fundamental
- Price
- ATLO $17.52
- PBYI $2.98
- Analyst Decision
- ATLO
- PBYI Strong Buy
- Analyst Count
- ATLO 0
- PBYI 1
- Target Price
- ATLO N/A
- PBYI $7.00
- AVG Volume (30 Days)
- ATLO 12.1K
- PBYI 386.8K
- Earning Date
- ATLO 05-07-2025
- PBYI 05-01-2025
- Dividend Yield
- ATLO 4.52%
- PBYI N/A
- EPS Growth
- ATLO N/A
- PBYI 37.78
- EPS
- ATLO 1.14
- PBYI 0.62
- Revenue
- ATLO $53,455,000.00
- PBYI $230,468,000.00
- Revenue This Year
- ATLO N/A
- PBYI N/A
- Revenue Next Year
- ATLO N/A
- PBYI $3.27
- P/E Ratio
- ATLO $15.58
- PBYI $4.83
- Revenue Growth
- ATLO 2.24
- PBYI N/A
- 52 Week Low
- ATLO $15.69
- PBYI $2.23
- 52 Week High
- ATLO $22.03
- PBYI $6.06
- Technical
- Relative Strength Index (RSI)
- ATLO 39.13
- PBYI 39.26
- Support Level
- ATLO $17.45
- PBYI $3.14
- Resistance Level
- ATLO $17.91
- PBYI $3.18
- Average True Range (ATR)
- ATLO 0.32
- PBYI 0.20
- MACD
- ATLO -0.05
- PBYI -0.06
- Stochastic Oscillator
- ATLO 23.30
- PBYI 4.38
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.